SPY425.26+0.95 0.22%
DIA344.30-0.82 -0.24%
IXIC14,174.14+104.72 0.74%

Immunogen Q1 EPS $(0.17) Beats $(0.19) Estimate, Sales $15.70M Miss $17.73M Estimate

Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is unchanged from the same period last year. The company reported

05/10/2021 06:31
Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is unchanged from the same period last year. The company reported quarterly sales of $15.70 million which missed the analyst consensus estimate of $17.73 million by 11.45 percent. This is a 18.16 percent increase over sales of $13.29 million the same period last year.